Cord Blood News Volume 7.34 | Sep 3 2015

Telomere Homeostasis in Trophoblasts and in Cord Blood Cells from Pregnancies Complicated with Preeclampsia
Researchers studied mechanisms of telomere shortening in trophoblasts from pregnancies complicated with preeclampsia (PE) and assessed telomere length and homeostasis in fetal cord blood cells from PE pregnancies. [Am J Obstet Gynecol] Abstract

Stem Cells Isolated from Human Dental Pulp and Amniotic Fluid Improve Skeletal Muscle Histopathology in Mdx/SCID Mice
Scientists investigated the potential of human dental pulp stem cells and human amniotic fluid stem cells to differentiate toward a skeletal myogenic lineage in order to determine the optimal conditions for achieving myogenic commitment. [Stem Cell Res Ther] Full Article

Human Amniotic Mesenchymal Stromal Cells (hAMSCs) as Potential Vehicles for Drug Delivery in Cancer Therapy: An In Vitro Study
Researchers investigated mesenchymal stromal cells isolated from the amniotic membrane of human term placenta as candidates for drug delivery in vitro. [Stem Cell Res Ther] Full Article

Repeated Autologous Umbilical Cord Blood Infusions Are Feasible and Had No Acute Safety Issues in Young Babies with Congenital Hydrocephalus
Investigators established the safety and feasibility of repeated intravenous infusions of autologous umbilical cord blood in young babies with congenital hydrocephalus. [Pediatr Res] Abstract

Visit our reviews page to see a complete list of reviews in the cord blood research field.

MD Anderson Cancer Center and Cellectis Announce a Broad Preclinical and Clinical Strategic Alliance in Cancer Immunotherapy
Cellectis and The University of Texas MD Anderson Cancer Center have entered into a research and development alliance aimed at bringing novel cellular immunotherapies to patients suffering from different types of liquid tumors. [MD Anderson Cancer Center] Press Release

NIH Awards Nearly $34 Million to UAB Center for Clinical and Translational Science
The National Institutes of Health (NIH) has awarded the University of Alabama at Birmingham (UAB) Center for Clinical and Translational Science $33.59 million over four years to continue the center’s programs advancing translational research. [University of Alabama at Birmingham] Press Release

From our sponsor: Learn how to form and isolate neural rosettes more efficiently. Watch the video.

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)

Visit our events page to see a complete list of events in the cord blood community.

Principal Scientist – Hematopoietic Products (STEMCELL Technologies Inc.)

Postdoctoral Fellow – HMGA Chromatin Remodeling Proteins in Cancer and Stem Cell Biology (Johns Hopkins University School of Medicine)

Assistant Member – Cord Blood (Fred Hutchinson Cancer Research Center)

Laboratory Technologist – Cord Blood and Cord Tissue Bank (Texas Stem Cell)

Postdoctoral Position – Hematopoietic Stem and Progenitor Cell Assays (Weill Cornell Medical School)

Postdoctoral Fellow – Hematopoietic Regeneration and Myeloid Malignancies (Weill-Cornell Medical College)

Research Associate – Cell Biology (Editas Medicine)

Independent Junior Group Leader – Lymphopoiesis or Gene Regulation/Nuclear Architecture in the Hematopoietic System (Max-Planck-Institute)

Postdoctoral Fellow – Immune Reconstitution in Hematopoietic Stem Cell Transplantation (Stanford University)

Research Associate – Leukemia, Stem Cells and Development (Josep Carreras Leukemia Research Institute)

Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.